Alteration and analyses of viral entry with library-derived peptides

被引:9
作者
Bupp, K [1 ]
Roth, MJ [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA
来源
ADVANCES IN VIRUS RESEARCH, VOL 65 | 2005年 / 65卷
关键词
D O I
10.1016/S0065-3527(05)65005-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The use of peptide libraries has revolutionized the ability to mutate and alter various properties of proteins. Initial studies employing peptide libraries utilized bacteriophage as a display platform (Cwirla et al., 1990; Devlin et al., 1990; Scott and Smith, 1990) or synthetic peptides on beads (Geysen et al., 1984; Lam et al., 1991). The initial applications screened simply for peptides binding to target molecules (streptavidin) (Devlin et al., 1990; Lam et al., 1991), or for peptide epitopes that bound to antibodies (Cwirla et al., 1990; Geysen et al., 1984; Scott and Smith, 1990). Since then, vast amounts of literature have been published employing peptide display libraries to alter and analyze various characteristics of proteins. In this chapter, we discuss the use of peptide libraries to examine and alter the interactions of mammalian viruses with cellular receptors. Investigations using antibodies derived from library screens to study immunological aspects of viruses and/or alter virus-cell interactions will not be discussed. Screening peptide libraries is a useful method for targeting retroviral, adenoviral, and adeno-associated viral gene therapy vectors to specific cells. In the case of adenovirus (Ad) and adeno-associated virus (AAV), peptides have been obtained from phage display libraries and attached to the surface of the virus, resulting in new targeting properties. Libraries of AAV and retroviral peptide display particles have also been employed in the development of gene therapy vectors. © 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:147 / 172
页数:26
相关论文
共 62 条
[1]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[2]   Mutational library analysis of selected amino acids in the receptor binding domain of envelope of Akv marine leukemia virus by conditionally replication competent bicistronic vectors [J].
Bahrami, S ;
Jespersen, T ;
Pedersen, FS ;
Duch, M .
GENE, 2003, 315 :51-61
[3]   RECEPTOR-BINDING DOMAIN OF MURINE LEUKEMIA-VIRUS ENVELOPE GLYCOPROTEINS [J].
BATTINI, JL ;
DANOS, O ;
HEARD, JM .
JOURNAL OF VIROLOGY, 1995, 69 (02) :713-719
[4]   In vivo selection of protease cleavage sites from retrovirus display libraries [J].
Buchholz, CJ ;
Peng, KW ;
Morling, FJ ;
Zhang, J ;
Cosset, FL ;
Russell, SJ .
NATURE BIOTECHNOLOGY, 1998, 16 (10) :951-954
[5]   Receptor targeting of adeno-associated virus vectors [J].
Büning, H ;
Ried, MU ;
Perabo, L ;
Gerner, FM ;
Huttner, NA ;
Enssle, J ;
Hallek, M .
GENE THERAPY, 2003, 10 (14) :1142-1151
[6]   Probing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries [J].
Bupp, K ;
Sarangi, A ;
Roth, MJ .
JOURNAL OF VIROLOGY, 2005, 79 (03) :1463-1469
[7]   Targeting a retroviral vector in the absence of a known cell-targeting ligand [J].
Bupp, K ;
Roth, MJ .
HUMAN GENE THERAPY, 2003, 14 (16) :1557-1564
[8]   Altering retroviral tropism using a random-display envelope library [J].
Bupp, K ;
Roth, MJ .
MOLECULAR THERAPY, 2002, 5 (03) :329-335
[9]   Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus [J].
Chertova, E ;
Bess, JW ;
Crise, BJ ;
Sowder, RC ;
Schaden, TM ;
Hilburn, JM ;
Hoxie, JA ;
Benveniste, RE ;
Lifson, JD ;
Henderson, LE ;
Arthur, LO .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5315-5325
[10]   Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors [J].
Christodoulopoulos, I ;
Cannon, PM .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4129-4138